Zinc effervescent tablets market seen reaching $44.9B by 2030

The zinc effervescent tablets market is forecast to grow from $31.29 billion in 2025 to $44.9 billion by 2030, driven by rising demand for dietary supplements, preventive healthcare and convenient immune-support products. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Zinc effervescent tablets are gaining traction as consumers look for fast-dissolving supplements that support immunity and daily nutrition. - The category sits at the intersection of preventive healthcare, self-medication and growing demand for functional wellness products. - The market’s forecast growth points to continued expansion across pharmacy, over-the-counter and e-commerce channels.

What happened: - The Business Research Company published a 2026 market report on the global zinc effervescent tablets market. - The market is projected to rise from $31.29 billion in 2025 to $33.74 billion in 2026. - The report forecasts the market will reach $44.9 billion by 2030. - The report estimates a 7.8% CAGR during the historical period and a 7.4% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - Zinc effervescent tablets dissolve in water and deliver zinc in a fizzy, easy-to-absorb form. - The tablets often include flavoring agents, citric acid and bicarbonates to improve taste and dissolution. - Rising awareness of zinc deficiency has supported demand for the category. - Growing pharmacy and over-the-counter supplement sales have also fueled growth. - Consumer demand for immune-support products has increased. - Limited availability of flavored effervescent options has helped drive interest in the segment. - Preventive healthcare, convenient dosage forms and e-commerce expansion are expected to support future growth. - Demand is also rising from geriatric and pediatric populations with higher nutritional needs. - The report highlights growing interest in sugar-free and diabetic-friendly zinc formulations. - Multivitamin-enriched zinc products are also gaining traction. - A free sample of the report is available through the company’s sample request page. - The full report is available here.

Between the lines: - The market is being pulled by a broader shift toward preventive, self-directed health spending rather than treatment-only care. - Zinc deficiency remains a meaningful demand driver because consumers and health systems are paying more attention to micronutrient intake. - The category’s growth also reflects a preference for supplements that are easier to take and more appealing than traditional tablets or capsules. - In Australia, 29.7% of people age 2 and older, or 7.3 million people, had inadequate zinc intake in March 2026. - Australian zinc intake deficiency rates were below 5% among children ages 2 to 11, but much higher among males than females, at 47.7% versus 11.2%. - UNICEF said in July 2024 that global coverage of adolescent girls receiving at least one HPV vaccine dose rose from 20% in 2022 to 27% in 2023.

What’s next: - The report expects immunity-focused, sugar-free and flavored zinc effervescent products to remain key growth areas. - Continued e-commerce adoption is likely to expand access and support sales through 2030. - Regional growth should remain uneven, with North America still a major market and Asia-Pacific expanding faster.

The bottom line: - Zinc effervescent tablets are moving from niche supplement to mainstream wellness product, and the market’s forecast growth reflects stronger consumer demand for convenient, preventive health solutions.